Circulating proteins detected by SWATH-MS in metastatic NSCLC patients treated with immunotherapy.

ABSTRACT: Immunotherapy has improved survival rates in NSCLC patients, but identifying those who will respond to treatment remains a challenge. We performed a differential proteomic quantitative analysis based on SWATH–MS technology to analyse the proteome in blood samples collected from patients with advanced NSCLC prior to the start therapy and during the therapy

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Non-small Cell Lung Carcinoma

SUBMITTER: Susana Bravo  

LAB HEAD: Susana Bravo

PROVIDER: PXD042091 | Pride | 2025-02-18

REPOSITORIES: Pride